The Leukemias of Mature Lymphocytes

Dores, 2007, Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology, Br J Haematol, 139, 809, 10.1111/j.1365-2141.2007.06856.x Hallek, 2008, Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, 111, 5446, 10.1182/blood-2007-06-093906 Binet, 1981, A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis, Cancer, 48, 198, 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V Rai, 1990, Prognostic factors and clinical staging in chronic lymphocytic leukemia, Hematol Oncol Clin North Am, 4, 447, 10.1016/S0889-8588(18)30497-0 Oscier, 1997, Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12, Br J Haematol, 98, 934, 10.1046/j.1365-2141.1997.3263141.x Frater, 2001, Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically, Am J Clin Pathol, 116, 655, 10.1309/7Q1J-1AA8-DU4Q-PVLQ Bennett, 1989, Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group, J Clin Pathol, 42, 567, 10.1136/jcp.42.6.567 Mueller-Hermelink, 2008, Chronic lymphocytic leukemia/small lymphocytic lymphoma, 180 Vallespi, 1991, Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients, Br J Haematol, 77, 478, 10.1111/j.1365-2141.1991.tb08613.x Lens, 1997, p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis, Br J Haematol, 99, 848, 10.1046/j.1365-2141.1997.4723278.x Matutes, 1996, Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients, Br J Haematol, 92, 382, 10.1046/j.1365-2141.1996.d01-1478.x Montserrat, 1996, Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients, Br J Haematol, 93, 111, 10.1046/j.1365-2141.1996.449988.x Raphael, 1988, Is bone marrow biopsy a prognostic parameter in B-CLL?, Nouv Rev Fr Hematol, 30, 377 Rozman, 1984, Bone marrow histologic pattern–the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases, Blood, 64, 642, 10.1182/blood.V64.3.642.642 Kjeldsberg, 1981, Prolymphocytic transformation of chronic lymphocytic leukemia, Cancer, 48, 2447, 10.1002/1097-0142(19811201)48:11<2447::AID-CNCR2820481118>3.0.CO;2-B Bessudo, 1995, Origin of high-grade lymphomas in Richter syndrome, Leuk Lymphoma, 18, 367, 10.3109/10428199509059634 Foucar, 1980, Richter's syndrome in chronic lymphocytic leukemia, Cancer, 46, 118, 10.1002/1097-0142(19800701)46:1<118::AID-CNCR2820460120>3.0.CO;2-J Nakamura, 2003, Richter syndrome in B-cell chronic lymphocytic leukemia, Pathol Int, 53, 195, 10.1046/j.1320-5463.2003.01455.x Foon, 1988, Clinical transformation of chronic lymphocytic leukemia, Nouv Rev Fr Hematol, 30, 385 Fayad, 1996, Hodgkin's disease variant of Richter's syndrome: experience at a single institution, Leuk Lymphoma, 23, 333, 10.3109/10428199609054836 Kanzler, 2000, Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease, Blood, 95, 1023, 10.1182/blood.V95.3.1023.003k07_1023_1031 Rubin, 1994, Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection, Mod Pathol, 7, 91 Ohno, 1998, Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin's transformation”, Blood, 91, 1757, 10.1182/blood.V91.5.1757 McCarron, 2000, Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders, Am J Clin Pathol, 113, 805, 10.1309/G689-2J36-KCTC-WD5N Matutes, 1994, The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL, Leukemia, 8, 1640 Damle, 1999, Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia, Blood, 94, 1840, 10.1182/blood.V94.6.1840 Hamblin, 2002, CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease, Blood, 99, 1023, 10.1182/blood.V99.3.1023 Del Poeta, 2001, Clinical significance of CD38 expression in chronic lymphocytic leukemia, Blood, 98, 2633, 10.1182/blood.V98.9.2633 Hsi, 2003, Prognostic Significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukemia (CLL), Br J Haematol, 120, 1017, 10.1046/j.1365-2141.2003.04213.x Admirand, 2004, Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma, Mod Pathol, 17, 954, 10.1038/modpathol.3800145 Orchard, 2004, ZAP-70 expression and prognosis in chronic lymphocytic leukaemia, Lancet, 363, 105, 10.1016/S0140-6736(03)15260-9 Rassenti, 2004, ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia, N Engl J Med, 351, 893, 10.1056/NEJMoa040857 Rassenti, 2008, Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia, Blood, 112, 1923, 10.1182/blood-2007-05-092882 Marti, 2006, ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue, Cytometry B Clin Cytom, 70, 197, 10.1002/cyto.b.20137 Hamblin, 2007, Prognostic markers in chronic lymphocytic leukaemia, Best Pract Res Clin Haematol, 20, 455, 10.1016/j.beha.2007.02.001 Dohner, 2000, Genomic alterations and survival in chronic lymphocytic leukemia, N Engl J Med, 343, 1910, 10.1056/NEJM200012283432602 Hamblin, 1999, Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia, Blood, 94, 1848, 10.1182/blood.V94.6.1848 Tobin, 2004, V(H)3–21 gene usage in chronic lymphocytic leukemia–characterization of a new subgroup with distinct molecular features and poor survival, Leuk Lymphoma, 45, 221, 10.1080/1042819031000147018 Tobin, 2002, Somatically mutated Ig V(H)3–21 genes characterize a new subset of chronic lymphocytic leukemia, Blood, 99, 2262, 10.1182/blood.V99.6.2262 Rosenwald, 2001, Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia, J Exp Med, 194, 1639, 10.1084/jem.194.11.1639 Wiestner, 2003, ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile, Blood, 101, 4944, 10.1182/blood-2002-10-3306 Matutes, 1994, The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders, Blood, 83, 1558, 10.1182/blood.V83.6.1558.1558 Lush, 1991, Polyclonal CD5 + B-lymphocytosis resembling chronic lymphocytic leukaemia, Br J Haematol, 79, 119, 10.1111/j.1365-2141.1991.tb08019.x Delage, 1998, All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements, Leuk Lymphoma, 31, 567, 10.3109/10428199809057616 Galton, 1974, Prolymphocytic leukemia, Br J Haematol, 27, 7, 10.1111/j.1365-2141.1974.tb06769.x Schlette, 2001, Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma, Am J Clin Pathol, 115, 571, 10.1309/PPK0-TJUK-1UAR-3194 Hsi, 2004, Advances in the diagnosis and classification of chronic lymphoproliferative disorders, Cancer Treat Res, 121, 145, 10.1007/1-4020-7920-6_6 Wong, 2002, Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia, Am J Clin Pathol, 117, 246, 10.1309/4LTE-JHNC-C8RC-FGWL Melo, 1986, The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group, Br J Haematol, 63, 377, 10.1111/j.1365-2141.1986.tb05563.x Campo, 2008, Prolymphocytic leukemia, 183 Lens, 2000, Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL), Leukemia, 14, 427, 10.1038/sj.leu.2401644 Lens, 1997, p53 abnormalities in B-cell prolymphocytic leukemia, Blood, 89, 2015, 10.1182/blood.V89.6.2015 Hercher, 2001, A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms, Leuk Lymphoma, 42, 981, 10.3109/10428190109097717 McCune, 2002, Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia, Leuk Lymphoma, 43, 1007, 10.1080/10428190290021597 Saven, 1997, Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia, J Clin Oncol, 15, 37, 10.1200/JCO.1997.15.1.37 Shvidel, 1999, B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course, Leuk Lymphoma, 33, 169, 10.3109/10428199909093739 Marti, 2007, Overview of monoclonal B-cell lymphocytosis, Br J Haematol, 139, 701, 10.1111/j.1365-2141.2007.06865.x Rawstron, 2008, Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia, N Engl J Med, 359, 575, 10.1056/NEJMoa075290 Goodman, 2003, Hairy cell leukemia: an update, Curr Opin Hematol, 10, 258, 10.1097/00062752-200307000-00002 Goodman, 2003, Extended follow-up of patients with hairy cell leukemia after treatment with cladribine, J Clin Oncol, 21, 891, 10.1200/JCO.2003.05.093 Kraut, 2003, Clinical manifestations and infectious complications of hairy-cell leukaemia, Best Pract Res Clin Haematol, 16, 33, 10.1016/S1521-6926(02)00085-3 Bethel, 2003, Pathology of hairy-cell leukaemia, Best Pract Res Clin Haematol, 16, 15, 10.1016/S1521-6926(02)00087-7 Macon, 1993, Marrow mast cell hyperplasia in hairy cell leukemia, Mod Pathol, 6, 695 Burke, 1984, The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen, Semin Oncol, 11, 334 DiGiuseppe, 1998, Clinical utility of flow cytometry in the chronic lymphoid leukemias, Semin Oncol, 25, 6 Matutes, 1994, The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes, Leuk Lymphoma, 14, 57 Robbins, 1993, Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia, Blood, 82, 1277, 10.1182/blood.V82.4.1277.1277 de Boer, 1996, Involvement of the CCND1 gene in hairy cell leukemia, Ann Oncol, 7, 251, 10.1093/oxfordjournals.annonc.a010568 Specht, 2002, Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections, Clin Cancer Res, 8, 2902 Del, 2004, The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes, Haematologica, 89, 303 Falini, 2004, Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1), Lancet, 363, 1869, 10.1016/S0140-6736(04)16356-3 Jasionowski, 2003, Analysis of CD10+ hairy cell leukemia, Am J Clin Pathol, 120, 228, 10.1309/QVJD31TEG9UJ18BQ Andersen, 2004, A narrow deletion of 7q is common to HCL, and SMZL, but not CLL, Eur J Haematol, 72, 390, 10.1111/j.1600-0609.2004.00243.x Sole, 1999, Cytogenetic findings in five patients with hairy cell leukemia, Cancer Genet Cytogenet, 110, 41, 10.1016/S0165-4608(98)00178-2 Forconi, 2008, High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia, Br J Haematol, 141, 622, 10.1111/j.1365-2141.2008.07106.x Arons, 2006, Somatic hypermutation and VH gene usage in hairy cell leukaemia, Br J Haematol, 133, 504, 10.1111/j.1365-2141.2006.06066.x Tiacci, 2006, Evolving concepts in the pathogenesis of hairy-cell leukaemia, Nat Rev Cancer, 6, 437, 10.1038/nrc1888 Basso, 2004, Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors, J Exp Med, 199, 59, 10.1084/jem.20031175 Grever, 2003, Pentostatin in the treatment of hairy-cell leukemia, Best Pract Res Clin Haematol, 16, 91, 10.1016/S1521-6926(03)00002-1 Tallman, 1999, Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse, Clin Cancer Res, 5, 1665 Cawley, 1980, A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia, Leuk Res, 4, 547, 10.1016/0145-2126(80)90066-1 Matutes, 2001, The natural history and clinico-pathological features of the variant form of hairy cell leukemia, Leukemia, 15, 184, 10.1038/sj.leu.2401999 Matutes, 2003, The variant form of hairy-cell leukaemia, Best Pract Res Clin Haematol, 16, 41, 10.1016/S1521-6926(02)00086-5 Munoz, 2001, Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies, Haematologica, 86, 1261 Traverse-Glehen, 2008, Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?, Blood, 111, 2253, 10.1182/blood-2007-07-098848 McKenna, 1977, Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics, Am J Med, 62, 588, 10.1016/0002-9343(77)90422-3 Loughran, 1985, Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia, Ann Intern Med, 102, 169, 10.7326/0003-4819-102-2-169 Loughran, 1993, Clonal diseases of large granular lymphocytes, Blood, 82, 1, 10.1182/blood.V82.1.1.bloodjournal8211 Lamy, 2003, Clinical features of large granular lymphocyte leukemia, Semin Hematol, 40, 185, 10.1016/S0037-1963(03)00133-1 Karadimitris, 2001, Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH, Br J Haematol, 115, 1010, 10.1046/j.1365-2141.2001.03172.x Lamy, 1999, Current concepts: large granular lymphocyte leukemia, Blood Rev, 13, 230, 10.1054/blre.1999.0118 Evans, 2000, Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia, Hum Pathol, 31, 1266, 10.1053/hupa.2000.19298 Morice, 2002, Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B, Blood, 99, 268, 10.1182/blood.V99.1.268 Langerak, 2001, Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations, Blood, 98, 165, 10.1182/blood.V98.1.165 Lima, 2001, Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease, Am J Pathol, 159, 1861, 10.1016/S0002-9440(10)63032-5 Beck, 2003, Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies, Am J Clin Pathol, 120, 785, 10.1309/835B04QXGNNFNRJU Ingen-Housz-Oro, 2002, A prospective study on the evolution of the T-cell repertoire in patients with Sezary syndrome treated by extracorporeal photopheresis, Blood, 100, 2168, 10.1182/blood.V100.6.2168 Lundell, 2005, T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules, Am J Clin Pathol, 124, 937, 10.1309/PH7X78HF4FW4PRKW Bourgault-Rouxel, 2008, Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 cases, Leuk Res, 32, 45, 10.1016/j.leukres.2007.04.011 Posnett, 1994, Clonal populations of T cells in normal elderly humans: the T cell equivalent to “benign monoclonal gammapathy”, J Exp Med, 179, 609, 10.1084/jem.179.2.609 Pandolfi, 1990, Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study, Cancer, 65, 341, 10.1002/1097-0142(19900115)65:2<341::AID-CNCR2820650227>3.0.CO;2-2 Dhodapkar, 1994, Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?, Blood, 84, 1620, 10.1182/blood.V84.5.1620.bloodjournal8451620 Morice, 2001, Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis, Leuk Lymphoma, 41, 277, 10.3109/10428190109057982 Rabbani, 1999, A long-term study of patients with chronic natural killer cell lymphocytosis, Br J Haematol, 106, 960, 10.1046/j.1365-2141.1999.01624.x Zambello, 1993, Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes, Blood, 81, 2381, 10.1182/blood.V81.9.2381.2381 Ohno, 1989, Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality, Cancer, 64, 63, 10.1002/1097-0142(19890701)64:1<63::AID-CNCR2820640111>3.0.CO;2-# Imamura, 1990, Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells, Br J Haematol, 75, 49, 10.1111/j.1365-2141.1990.tb02615.x Matutes, 1991, Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia, Blood, 78, 3269, 10.1182/blood.V78.12.3269.3269 Hoyer, 1995, True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases, Blood, 86, 1163, 10.1182/blood.V86.3.1163.1163 Matutes, 1996, Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia, Blood, 87, 3520, 10.1182/blood.V87.8.3520.bloodjournal8783520 Garand, 1998, Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d'Hematologie Cellulaire, Br J Haematol, 103, 488, 10.1046/j.1365-2141.1998.00977.x Matutes, 1986, The morphological spectrum of T-prolymphocytic leukemia, Br J Haematol, 64, 111, 10.1111/j.1365-2141.1986.tb07579.x Mallett, 1995, Cutaneous infiltration in T-cell prolymphocytic leukaemia, Br J Dermatol, 132, 263, 10.1111/j.1365-2133.1995.tb05023.x Valbuena, 2005, T-cell prolymphocytic leukemia involving extramedullary sites, Am J Clin Pathol, 123, 456, 10.1309/93P42RNG5XBG3KBE Herling, 2004, A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories, Blood, 104, 328, 10.1182/blood-2004-01-0002 Maljaei, 1998, Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization, Cancer Genet Cytogenet, 103, 110, 10.1016/S0165-4608(97)00410-X Virgilio, 1998, Deregulated expression of TCL1 causes T cell leukemia in mice, Proc Natl Acad Sci U S A, 95, 3885, 10.1073/pnas.95.7.3885 Gritti, 1998, Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia, Blood, 92, 368, 10.1182/blood.V92.2.368 Johnson, 2006, Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia, Blood, 108, 1334, 10.1182/blood-2005-12-011213 Laine, 2000, The protooncogene TCL1 is an Akt kinase coactivator, Mol Cell, 6, 395, 10.1016/S1097-2765(00)00039-3 Pekarsky, 2004, Tcl1 as a model for lymphomagenesis, Hematol Oncol Clin North Am, 18, 863, 10.1016/j.hoc.2004.04.007 Pekarsky, 2000, Tcl1 enhances Akt kinase activity and mediates its nuclear translocation, Proc Natl Acad Sci U S A, 97, 3028, 10.1073/pnas.040557697 Soma, 2002, Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?, Am J Hematol, 71, 224, 10.1002/ajh.10221 Yokohama, 2000, Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities, J Med, 31, 183 Herling, 2008, High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia, Blood, 111, 328, 10.1182/blood-2007-07-101519 Cao, 2003, T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H), Hematology, 8, 1, 10.1080/1024533021000059465 Dearden, 2001, High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, Blood, 98, 1721, 10.1182/blood.V98.6.1721 Fraser-Andrews, 2001, Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sezary syndrome, Cancer, 92, 1745, 10.1002/1097-0142(20011001)92:7<1745::AID-CNCR1689>3.0.CO;2-0 Duncan, 1978, Circulating Sezary cells in hospitalized dermatology patients, Br J Dermatol, 99, 171, 10.1111/j.1365-2133.1978.tb01978.x Bogen, 1996, Immunophenotypic identification of Sezary cells in peripheral blood, Am J Clin Pathol, 106, 739, 10.1093/ajcp/106.6.739 Harmon, 1996, Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses, J Am Acad Dermatol, 35, 404, 10.1016/S0190-9622(96)90605-2 Vonderheid, 2001, Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome), J Invest Dermatol, 117, 654, 10.1046/j.1523-1747.2001.01456.x Jones, 2001, Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood, Am J Clin Pathol, 115, 885, 10.1309/U1Y6-J4AG-5M4M-7AYV Bernengo, 2001, The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells, Br J Dermatol, 144, 125, 10.1046/j.1365-2133.2001.04014.x Bahler, 2008, CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry, Cytometry B Clin Cytom, 74, 156, 10.1002/cyto.b.20395 Schwab, 2002, The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas, Br J Haematol, 118, 1019, 10.1046/j.1365-2141.2002.03726.x Klemke, 2008, The diagnosis of Sezary syndrome on peripheral blood by flow cytometry requires the use of multiple markers, Br J Dermatol, 159, 871, 10.1111/j.1365-2133.2008.08739.x Vermeer, 2008, Novel and highly recurrent chromosomal alterations in Sezary syndrome, Cancer Res, 68, 2689, 10.1158/0008-5472.CAN-07-6398 Willemze, 2005, WHO-EORTC classification for cutaneous lymphomas, Blood, 105, 3768, 10.1182/blood-2004-09-3502 Matutes, 2007, Adult T-cell leukaemia/lymphoma, J Clin Pathol, 60, 1373, 10.1136/jcp.2007.052456 Karube, 2004, Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells, Br J Haematol, 126, 81, 10.1111/j.1365-2141.2004.04999.x Shimauchi, 2008, Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells, Cancer Sci, 99, 98 Kamihira, 2005, Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells, Clin Lab Haematol, 27, 235, 10.1111/j.1365-2257.2005.00698.x